Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
100
datasets available to search
ShareScore release 0.9.0
Dataset results
100 results for “Yellow fever”
The molecular basis for the attenuation of the yellow fever 17D vaccine [SHAPEmap]
GEO Series GSE275593. Yellow fever virus. 12 samples. Type: Other.
Whole genome DNA methylation analysis of human CD8 T cell specific for the Yellow fever virus vaccine
GEO Series GSE75533. Homo sapiens. 4 samples. Type: Methylation profiling by high throughput sequencing.
CRISPR screen for interferon-alpha inducible inhibitors of yellow fever virus replication
GEO Series GSE121710. Homo sapiens. 2 samples. Type: Other.
Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine
GEO Series GSE293880. Homo sapiens. 36 samples. Type: Expression profiling by high throughput sequencing.
Data from: Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis
Background: Substantial outbreaks of yellow fever in Angola and Brazil in the past 2 years, combined with global shortages in vaccine stockpiles, highlight a pressing need to assess present control strategies. The aims of this study were to estimate global yellow fever vaccination coverage from 1970 through to 2016 at high spatial resolution and to calculate the number of individuals still requiring vaccination to reach population coverage thresholds for outbreak prevention. Methods: For this adjusted retrospective analysis, we compiled data from a range of sources (eg, WHO reports and health-service-provider registeries) reporting on yellow fever vaccination activities between May 1, 1939, and Oct 29, 2016. To account for uncertainty in how vaccine campaigns were targeted, we calculated three population coverage values to encompass alternative scenarios. We combined these data with demographic information and tracked vaccination coverage through time to estimate the proportion of the population who had ever received a yellow fever vaccine for each second level administrative division across countries at risk of yellow fever virus transmission from 1970 to 2016. Findings: Overall, substantial increases in vaccine coverage have occurred since 1970, but notable gaps still exist in contemporary coverage within yellow fever risk zones. We estimate that between 393·7 million and 472·9 million people still require vaccination in areas at risk of yellow fever virus transmission to achieve the 80% population coverage threshold recommended by WHO; this represents between 43% and 52% of the population within yellow fever risk zones, compared with between 66% and 76% of the population who would have required vaccination in 1970. Interpretation: Our results highlight important gaps in yellow fever vaccination coverage, can contribute to improved quantification of outbreak risk, and help to guide planning of future vaccination efforts and emergency stockpiling.
Yellow Fever Vaccine on Statin/ Non Statin Subjects
ClinicalTrials.gov study NCT03116802. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination
ClinicalTrials.gov study NCT01244802. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19
ClinicalTrials.gov study NCT03891420. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination
ClinicalTrials.gov study NCT00708630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Yellow Fever Vaccination Under Low Dose Methotrexate Therapy
ClinicalTrials.gov study NCT02383680. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine
ClinicalTrials.gov study NCT01290055. IPD Sharing: NO. Countries: 1. Publications: 0.
Yellow Fever Human Infection Model With YF-17D
ClinicalTrials.gov study NCT05901454. IPD Sharing: NO. Countries: 1. Publications: 0.
VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)
ClinicalTrials.gov study NCT06694766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Description of the Immune Response to Yellow Fever Vaccination
ClinicalTrials.gov study NCT06718127. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults
ClinicalTrials.gov study NCT00616356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults
ClinicalTrials.gov study NCT06998004. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
ClinicalTrials.gov study NCT03938597. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
ClinicalTrials.gov study NCT05859490. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
ClinicalTrials.gov study NCT02555072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"
ClinicalTrials.gov study NCT03591003. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.